Literature DB >> 15975004

Helper functions required for wild type and recombinant adeno-associated virus growth.

Marie-Claude Geoffroy1, Anna Salvetti.   

Abstract

The human parvovirus Adeno-Associated virus (AAV-2) has been classified as a Dependovirus because it requires the presence of a helper virus to achieve a productive replication cycle. Several viruses such as Adenovirus (Ad), Herpes Simplex Virus (HSV), Vaccinia virus, and human papillomaviruses (HPV) can provide the helper activities required for AAV growth. The studies on the helper activities provided by adenovirus have provided useful information not only to understand the AAV-2 biology but also to develop tools for the production of recombinant AAV particles (rAAV). This review will focus on the current knowledge about the helper activities provided by the most extensively studied helper viruses, Ad and HSV-1, and also illustrate the methods used to supply the helper functions rAAV assembly.

Entities:  

Mesh:

Year:  2005        PMID: 15975004     DOI: 10.2174/1566523054064977

Source DB:  PubMed          Journal:  Curr Gene Ther        ISSN: 1566-5232            Impact factor:   4.391


  39 in total

1.  Impact of the MRN Complex on Adeno-Associated Virus Integration and Replication during Coinfection with Herpes Simplex Virus 1.

Authors:  Rachel Millet; Nelly Jolinon; Xuan-Nhi Nguyen; Gregory Berger; Andrea Cimarelli; Anna Greco; Pascale Bertrand; Margarete Odenthal; Hildegard Büning; Anna Salvetti
Journal:  J Virol       Date:  2015-04-22       Impact factor: 5.103

Review 2.  Parvovirus glycan interactions.

Authors:  Lin-Ya Huang; Sujata Halder; Mavis Agbandje-McKenna
Journal:  Curr Opin Virol       Date:  2014-07-19       Impact factor: 7.090

3.  Identification of rep-associated factors in herpes simplex virus type 1-induced adeno-associated virus type 2 replication compartments.

Authors:  Armel Nicolas; Nathalie Alazard-Dany; Coline Biollay; Loredana Arata; Nelly Jolinon; Lauriane Kuhn; Myriam Ferro; Sandra K Weller; Alberto L Epstein; Anna Salvetti; Anna Greco
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

4.  Structural characterization of the dual glycan binding adeno-associated virus serotype 6.

Authors:  Robert Ng; Lakshmanan Govindasamy; Brittney L Gurda; Robert McKenna; Olga G Kozyreva; R Jude Samulski; Kristin N Parent; Timothy S Baker; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

5.  Parvovirus infection-induced DNA damage response.

Authors:  Yong Luo; Jianming Qiu
Journal:  Future Virol       Date:  2013-03-01       Impact factor: 1.831

6.  Does human bocavirus infection depend on helper viruses? A challenging case report.

Authors:  Monika Streiter; Monika Malecki; Aram Prokop; Verena Schildgen; Jessica Lüsebrink; Andreas Guggemos; Matthias Wisskirchen; Michael Weiss; Reinhold Cremer; Michael Brockmann; Oliver Schildgen
Journal:  Virol J       Date:  2011-08-29       Impact factor: 4.099

7.  Structure and dynamics of adeno-associated virus serotype 1 VP1-unique N-terminal domain and its role in capsid trafficking.

Authors:  Balasubramanian Venkatakrishnan; Joseph Yarbrough; John Domsic; Antonette Bennett; Brian Bothner; Olga G Kozyreva; R Jude Samulski; Nicholas Muzyczka; Robert McKenna; Mavis Agbandje-McKenna
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

8.  Promyelocytic leukemia protein is a cell-intrinsic factor inhibiting parvovirus DNA replication.

Authors:  Angela M Mitchell; Matthew L Hirsch; Chengwen Li; R Jude Samulski
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

9.  The Mre11/Rad50/Nbs1 complex limits adeno-associated virus transduction and replication.

Authors:  Rachel A Schwartz; Jose Alejandro Palacios; Geoffrey D Cassell; Sarah Adam; Mauro Giacca; Matthew D Weitzman
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

Review 10.  Cellular transduction mechanisms of adeno-associated viral vectors.

Authors:  Garrett Edward Berry; Aravind Asokan
Journal:  Curr Opin Virol       Date:  2016-08-18       Impact factor: 7.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.